Arthur A. Levin, Director at Avidity Biosciences, Inc. (RNA), sold 10,000 shares at $37.59 ($376K) on 2024-06-20, disclosed to the SEC on 2024-06-21.
Scheduled sale ($376k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.59 | 5,000 | $188K | 50.0% |
| 2 | $37.59 | 5,000 | $188K | 50.0% |
| Total | $37.59 avg | 10,000 | $376K | 100% |
| Filing → |
| RNA | SELL | 2025-08-08 | $5.1M | — | Filing → |
| RNA | SELL | 2025-01-23 | $107K | — | Filing → |
| RNA | SELL | 2024-11-20 | $280K | — | Filing → |